NDC 0169-2100

NOVOLOG

Insulin Aspart

NOVOLOG is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Insulin Aspart.

• Product ID: 0169-2100_701d5c2d-21d9-414a-a946-236bcb198a37
• NDC: 0169-2100
• Product Type: Human Prescription Drug
• Proprietary Name: NOVOLOG
• Generic Name: Insulin Aspart
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS; SUBCUTANEOUS
• Marketing Start Date: 2001-08-27
• Marketing Category: BLA /
• Application Number: BLA020986
• Labeler Name: Novo Nordisk
• Substance Name: INSULIN ASPART
• Active Ingredient Strength: 100 [iU]/mL
• Pharm Classes: Insulin [CS],Insulin Analog [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 0169-2100-11

1 VIAL, GLASS in 1 CARTON (0169-2100-11) > 10 mL in 1 VIAL, GLASS

• Marketing Start Date: 2021-05-25
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "NOVOLOG" or generic name "Insulin Aspart"

NDC	Brand Name	Generic Name
0169-2100	NOVOLOG	insulin aspart
0169-2101	NOVOLOG	insulin aspart
0169-3303	NOVOLOG	insulin aspart
0169-6338	NOVOLOG	insulin aspart
0169-6339	NOVOLOG	insulin aspart
0169-7501	NOVOLOG	insulin aspart
50090-1664	NOVOLOG	insulin aspart
50090-1665	NovoLog	insulin aspart
50090-1678	NOVOLOG	insulin aspart
68258-8899	NovoLog	NovoLog
64725-0750	NovoLog	NovoLog
70518-2252	NOVOLOG	NOVOLOG
0169-2200	NovoLog Mix 70/30	insulin aspart
0169-2201	NovoLog Mix 70/30	insulin aspart
0169-3685	NovoLog Mix 70/30	insulin aspart
0169-3696	NovoLog Mix 70/30	insulin aspart